Inhibition of A549 cell proliferation by RNA interfered gene her2/neu
Fang Zhang
Abstract
Fang Zhang
Abstract
Objective:The effect of HER2/neu expression on the proliferation of A549 cell is not clear. We inhibited the HER2/neu expression with RNA interference (RNAi) technique,and investigated the proliferation of A549 cell in this study. Methods:Firstly a recombinant RNAi expression plasmid targeting to her2/neu gene (named psilence 3.1-HER2) was constructed. After RNAi plasmids being transfected to A549 cells with Lipofectamine,the positive clones were screened with G418. The expression changes of HER2/neu mRNA and protein were evaluated with RT-PCR and Western Blot respectively; Also FCM analysis,MTT method were applied to measure cell cycle,cell growth of A549 cell respectively after the transfection of psilence 3.1-HER2. Results:The psilence 3.1-HER2 was successfully constructed and can specially inhibit HER2/neu mRNA and protein expression after transfection. FCM results showed that cells transfected with psilence 3.1-HER2 increased accumulation of cells in G0/G1 phase with a decrease in the percentage of cells in S-phase,and the growth curve of cells exhibited slower proliferation. Conclusion:The psilence 3.1-HER2 can knockdown her2/neu gene specially and efficiently,transfection of psilence 3.1-HER2 contributes to the depression of A549 cell proliferation. The data described here provided a proof of the concept that vector-based RNAi targeting to her2/neu gene could be used therapeutically for lung cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:The effect of HER2/neu expression on the proliferation of A549 cell is not clear. We inhibited the HER2/neu expression with RNA interference (RNAi) technique,and investigated the proliferation of A549 cell in this study. Methods:Firstly a recombinant RNAi expression plasmid targeting to her2/neu gene (named psilence 3.1-HER2) was constructed. After RNAi plasmids being transfected to A549 cells with Lipofectamine,the positive clones were screened with G418. The expression changes of HER2/neu mRNA and protein were evaluated with RT-PCR and Western Blot respectively; Also FCM analysis,MTT method were applied to measure cell cycle,cell growth of A549 cell respectively after the transfection of psilence 3.1-HER2. Results:The psilence 3.1-HER2 was successfully constructed and can specially inhibit HER2/neu mRNA and protein expression after transfection. FCM results showed that cells transfected with psilence 3.1-HER2 increased accumulation of cells in G0/G1 phase with a decrease in the percentage of cells in S-phase,and the growth curve of cells exhibited slower proliferation. Conclusion:The psilence 3.1-HER2 can knockdown her2/neu gene specially and efficiently,transfection of psilence 3.1-HER2 contributes to the depression of A549 cell proliferation. The data described here provided a proof of the concept that vector-based RNAi targeting to her2/neu gene could be used therapeutically for lung cancer.
Key concepts: Transfection, Lipofectamine, RNA interference, Molecular biology, Cell growth, A549 cell, Gene knockdown, Biology